Patent ID: 7671079
Filing Date: 2010-03-02
Classification: A61K,A61P,C07D

Abstract:
1. A method for the treatment of a central nervous system disorder related to or affected by the 5-HT6 receptor in a patient in need thereof which comprises providing to said patient a therapeutically effective amount of a compound of formula I wherein X is CR n is an integer of 1 or 2; R R R R R R R R x and m are each independently 0 or an integer of 1 or 2; or a stereoisomer thereof or a pharmaceutically acceptable salt thereof; wherein the central nervous system disorder related to or affected by the 5-HT6 receptor is selected from the group consisting of an anxiety disorder; a cognitive disorder; attention deficit disorder; obsessive compulsive disorder; withdrawal from drug, alcohol or nicotine addiction; schizophrenia; depression; Alzheimer's disease; stroke; head trauma; and neuropathic pain.